Does PEGINTERFERON LAMBDA-1A Cause Hyperbilirubinaemia? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hyperbilirubinaemia have been filed in association with PEGINTERFERON LAMBDA-1A. This represents 10.0% of all adverse event reports for PEGINTERFERON LAMBDA-1A.
7
Reports of Hyperbilirubinaemia with PEGINTERFERON LAMBDA-1A
10.0%
of all PEGINTERFERON LAMBDA-1A reports
1
Deaths
2
Hospitalizations
How Dangerous Is Hyperbilirubinaemia From PEGINTERFERON LAMBDA-1A?
Of the 7 reports, 1 (14.3%) resulted in death, 2 (28.6%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Hyperbilirubinaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGINTERFERON LAMBDA-1A. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does PEGINTERFERON LAMBDA-1A Cause?
Jaundice (18)
Rash (18)
Alanine aminotransferase increased (8)
Aspartate aminotransferase increased (8)
Pyrexia (7)
Ascites (6)
Haemoglobin decreased (6)
Hepatic failure (6)
Sleep disorder (6)
Affective disorder (5)
What Other Drugs Cause Hyperbilirubinaemia?
METHOTREXATE (603)
RIBAVIRIN (560)
VINCRISTINE (479)
CYTARABINE (397)
PEGASPARGASE (349)
ACETAMINOPHEN (330)
CYCLOPHOSPHAMIDE (330)
DEXAMETHASONE (315)
CAPECITABINE (279)
SOFOSBUVIR (260)